Related Experiment Videos

Ophthalmic zoster: mucous plaque keratitis

R J Marsh1, M Cooper

  • 1Department of Clinical Ophthalmology, Moorfields Eye Hospital, London.

Insights

Zoster mucous plaque keratitis (MPK) presents as greyish plaques, often with complications if delayed. Prompt treatment with steroids and acetylcysteine typically resolves MPK within a month, though surgery may be needed for severe cases.

Area of Science:

  • Ophthalmology
  • Infectious Diseases

Background:

  • Herpes zoster ophthalmicus can lead to severe ocular complications.
  • Zoster mucous plaque keratitis (MPK) is a specific manifestation requiring characterization.

Purpose of the Study:

  • To characterize the clinical presentation and behavior of zoster mucous plaque keratitis (MPK).
  • To identify factors influencing MPK complications and outcomes.

Main Methods:

  • Retrospective analysis of 1221 patients with MPK from Moorfields Eye Hospital Zoster Clinic over 15 years.
  • Clinical data review including presentation, associated conditions, treatment, and surgical outcomes.

Main Results:

  • MPK typically presents with greyish plaques, limbitis, stromal keratitis, and decreased corneal sensation.
  • Associated conditions include cataracts, elevated intraocular pressure, and corneal ulceration.
  • Delayed MPK onset (after 3 months) correlates with increased complications; most cases resolve within a month with topical steroids and acetylcysteine, but surgery is sometimes necessary.

Conclusions:

  • MPK requires prompt diagnosis and management to prevent complications.
  • Topical steroids and acetylcysteine are effective initial treatments.
  • Surgical intervention for MPK-related complications like glaucoma or cataracts yields good results.

Related Concept Videos